Forskning ved Københavns Universitet - Københavns Universitet

Forside

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Dick de Zeeuw
  • Rajiv Agarwal
  • Michael Amdahl
  • Paul Audhya
  • Daniel Coyne
  • Tushar Garimella
  • Hans-Henrik Parving
  • Yili Pritchett
  • Giuseppe Remuzzi
  • Eberhard Ritz
  • Dennis Andress
Despite treatment with renin–angiotensin–aldosterone system (RAAS) inhibitors, patients with diabetes have increased risk of progressive renal failure that correlates with albuminuria. We aimed to assess whether paricalcitol could be used to reduce albuminuria in patients with diabetic nephropathy.
OriginalsprogEngelsk
TidsskriftLancet
Vol/bind376
Udgave nummer9752
Sider (fra-til)1543-51
Antal sider9
ISSN0140-6736
DOI
StatusUdgivet - 6 nov. 2010

ID: 34163362